{"id":1236,"date":"2013-04-06T16:56:28","date_gmt":"2013-04-06T16:56:28","guid":{"rendered":"http:\/\/www.kriesi.at\/themes\/enfold\/?page_id=1236"},"modified":"2021-03-23T15:38:13","modified_gmt":"2021-03-23T15:38:13","slug":"pharmacovigilance","status":"publish","type":"page","link":"https:\/\/meditrina.gr\/en\/pharmacovigilance\/","title":{"rendered":"pharmacovigilance"},"content":{"rendered":"
\n
<\/div><\/div><\/div><\/div>

PHARMACOVIGILANCCE<\/h3>
<\/div><\/div><\/div>
\n

Meditrina<\/span> as a responsible marketing authorization holder has set up an appropriate system for the monitoring, collection, report, assessment, understanding and prevention of adverse reactions concerning our products.<\/p>\n

Meditrina has appointed Pharmassist CRO<\/span> as the qualified Pharmacovigilance partner. Pharmassist CRO<\/span> is responsible for the management of the Pharmacovigilance & Risk Management System, reporting of suspected adverse reactions to the Authorities, submission of Periodic Safety Update Reports (PSUR) and management of Spontaneous Reporting Program (SRP).<\/p>\n

The Pharmacovigilance system of our company complies with EU and Greek legal standards and strict requirements of Greek Regulatory Authorities (EOF<\/span>) and EMEA<\/span>.<\/p>\n

If you would like to report any adverse reaction or pregnancy please dial +30 <\/span>210 6561435 <\/span>at any time.<\/p>\n<\/div><\/section><\/p><\/div><\/div><\/div><\/main><\/div><\/div>